Kissing may spread human herpes virus 8, the cause of Kaposi's sarcoma, among men

November 07, 2000

Most people do not think of kissing as a way of spreading serious sexually transmitted diseases. But kissing between men may be what spreads human herpes virus 8 (HHV-8), the cause of Kaposi's sarcoma, according to researchers at the University of Washington and the Fred Hutchinson Cancer Research Center in Seattle.

The findings are published in the article, "Mucosal Shedding of Human Herpes Virus 8 in Men," in the Nov. 9 New England Journal of Medicine.

Kaposi's sarcoma is a tumor that usually appears as purplish raised blotches on the skin or in the mouth. It can also form inside internal body cavities, such as the abdomen and chest. This cancer has been recognized for centuries among people living in Southern Europe, the Middle East and Africa, but became more frequent in the United States and Western Europe in the early 1980s. At that time, an epidemic of Kaposi¹s sarcoma in homosexual men was what heralded the arrival of the AIDS epidemic.

Kaposi's sarcoma most often occurs in people with compromised or suppressed immune systems. That is why it attacks people with AIDS. That is also why it is also sometimes found in people who have received organ transplants -- they take medications to suppress their immune system in order to reduce the risk that the body will reject the new, foreign organ. The cancer can usually be treated effectively with chemotherapy, though occasionally, it can spread to internal organs and prove fatal.

HHV-8 was first characterized in 1994 by researchers at Columbia University who found it to be associated with Kaposi's sarcoma. HHV-8 is the latest recognized addition to a family of human herpes viruses that include those responsible for oral and genital herpes, chickenpox and infectious mononucleosis. Although previous studies had indicated that in the United States HHV-8 was more common among people with many sexual partners, the exact mechanism of transmission remains unclear. In addition, in Africa and in Southern Europe, the virus is found in children as well as adults, suggesting that non-sexual spread can occur.

"When we think of STDs, we traditionally think of infections which are spread through sexual contact. It turned out that HHV-8 has been very hard to find in genital secretions. One of the reasons people started looking at the mouth is because Kaposi's sarcoma often shows up first as lesions in the mouth," says Dr. John Pauk, the lead author, who conducted the study during his fellowship in infectious diseases at the UW School of Medicine. He is now in private practice. "We found the virus in the mouth more often and in higher amounts than in genital secretions."

So far, the virus has been very difficult to grow in the laboratory and techniques to detect the virus have relied on detection of the viral DNA in the laboratory of Dr. Meei-Li Huang, research scientist at Fred Hutchinson Cancer Research Center. These findings are strengthened by studies performed by Dr. Scott Brodie, research assistant professor in the Department of Laboratory Medicine and director of molecular virology laboratories at the UW School of Medicine. Dr. Brodie showed that HHV-8 replicates in the cells that line the mouth.

Among men who have sex with men in Seattle, the virus was found in about 40 percent of the men with HIV infection and about 20 percent of men without HIV.

The study analyzed 112 men who have sex with men and found three independent risk factors for infection with HHV-8: Despite the large percentage of men in Seattle who were infected with HHV-8, Kaposi's sarcoma is less common now than in the early days of the AIDS epidemic. This may be largely due to the success in treating patients with AIDS using drugs that halt the damage done to the body¹s immune system.

"Currently, the number of people who go from infection with HHV-8 to any clinical syndrome is very low. Even if you become infected with HHV-8, your risk of developing cancer is very slim," Pauk said. Most people infected with HHV-8 are without symptoms.

The public health ramifications of this study remain unclear. Researchers are not telling people to modify their sexual practices. But they are suggesting that men who have sex with men, especially those with HIV infection, should be aware of the risks that might be associated with deep kissing.

"'Safer sex' messages have focused on exposure to genital secretions. The issue that this paper raises is that kissing can also be a risk for a virus," said one of the paper's authors, Dr. Anna Wald. She is director of the UW Virology Research Clinic and an assistant professor of allergy and infectious diseases in the UW School of Medicine and of epidemiology in the School of Public Health and Community Medicine.
-end-
The other co-authors on this paper include Dr. Lawrence Corey of the UW and a member of the clinical research division of Fred Hutchinson Cancer Research Center; Dr. David Koelle, Dr. Connie Celum and Stacy Selke of the UW; and Dr. Timothy Schacker of the University of Minnesota.

The UW Virology Research Clinic is undertaking more studies to examine HHV-8 transmission and infections. Researchers are particularly looking for couples of gay men who can be followed over time. For more information, call the clinic at (206) 720-4340.

University of Washington

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.